Clinical immunology

You have free access to this content

Suppressive and pro-inflammatory roles for IL-4 in the pathogenesis of experimental drug-induced liver injury

  1. Dolores B. Njoku1,2,3,*,
  2. Zhaoxia Li1,
  3. Nicole D. Washington2,
  4. Jenelle L. Mellerson3,
  5. Monica V. Talor3,
  6. Rajni Sharma3,
  7. Noel R. Rose3,4

Article first published online: 4 JUN 2009

DOI: 10.1002/eji.200838135

Issue

European Journal of Immunology

European Journal of Immunology

Volume 39, Issue 6, pages 1652–1663, June 2009

Additional Information

How to Cite

Njoku, D. B., Li, Z., Washington, N. D., Mellerson, J. L., Talor, M. V., Sharma, R. and Rose, N. R. (2009), Suppressive and pro-inflammatory roles for IL-4 in the pathogenesis of experimental drug-induced liver injury. Eur. J. Immunol., 39: 1652–1663. doi: 10.1002/eji.200838135

Author Information

  1. 1

    Department of Anesthesiology and Critical Care Medicine, The Johns Hopkins Medical Institutions, Baltimore, MD, USA

  2. 2

    Department of Pediatrics, The Johns Hopkins Medical Institutions, Baltimore, MD, USA

  3. 3

    Department of Pathology, The Johns Hopkins Medical Institutions, Baltimore, MD, USA

  4. 4

    W. Harvey Feinstone Department of Molecular Microbiology and Immunology, The Johns Hopkins Medical Institutions, Baltimore, MD, USA

*Departments of Anesthesiology and Critical Care Medicine, Pediatrics and Pathology, Johns Hopkins Medical Institutions, 600 North Wolfe Street, Blalock 906A, Baltimore, MD 21287, USA Fax: +1-410-502-5312

Publication History

  1. Issue published online: 4 JUN 2009
  2. Article first published online: 4 JUN 2009
  3. Manuscript Accepted: 31 MAR 2009
  4. Manuscript Revised: 12 FEB 2009
  5. Manuscript Received: 2 JAN 2008

Funded by

  • Unknown funding agency. Grant Number: NIHR21DK075828
  • American Autoimmune Related Diseases Association
  • The Gail I Zuckerman Foundation

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (457K)

References

  • 1
    Schiodt, F. V., Atillasoy, E., Shakil, A. O., Schiff, E. R., Caldwell, C., Kowdley, K. V., Stribling, R. et al., Etiology and outcome for 295 patients with acute liver failure in the United States. Liver Transpl. Surg. 1999. 5: 29–34.
    Direct Link:
  • 2
    Ostapowicz, G., Fontana, R. J., Schiodt, F. V., Larson, A., Davern, T. J., Han, S. H., McCashland, T. M. et al., Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States. Ann. Intern. Med. 2002. 137: 947–954.
  • 3
    Masubuchi, Y., Bourdi, M., Reilly, T. P., Graf, M. L., George, J. W. and Pohl, L. R., Role of interleukin-6 in hepatic heat shock protein expression and protection against acetaminophen-induced liver disease. Biochem. Biophys. Res. Commun. 2003. 304: 207–212.
  • 4
    Castell, J. V., Allergic hepatitis: a drug-mediated organ-specific immune reaction. Clin. Exp. Allergy 1998. 28:13–19.
  • 5
    Adkinson, N. F., Jr., Essayan, D., Gruchalla, R., Haggerty, H., Kawabata, T., Sandler, J. D., Updyke, L. et al., Task force report: future research needs for the prevention and management of immune-mediated drug hypersensitivity reactions. J. Allergy Clin. Immunol. 2002. 109: S461–S478.
  • 6
    Bourdi, M., Chen, W., Peter, R. M., Martin, J. L., Buters, J. T., Nelson, S. D., and Pohl, L. R., Human cytochrome P450 2E1 is a major autoantigen associated with halothane hepatitis. Chem. Res. Toxicol. 1996. 9: 1159–1166.
  • 7
    Mackay, I. R. and Toh, B. H., Autoimmune hepatitis: the way we were, the way we are today and the way we hope to be. Autoimmunity 2002. 35: 293–305.
  • 8
    Neuberger, J., Mieli-Vergani, G., Tredger, J. M., Davis, M. and Williams, R., Oxidative metabolism of halothane in the production of altered hepatocyte membrane antigens in acute halothane-induced hepatic necrosis. Gut 1981. 22: 669–672.
  • 9
    Pohl, L. R., Thomassen, D., Pumford, N. R., Butler, L. E., Satoh, H. and Ferrans, V. J., Hapten carrier conjugates associated with halothane hepatitis. Adv. Exp. Med. Biol. 1991. 283: 111–120.
  • 10
    Njoku, D., Laster, M. J., Gong, D. H., Eger, E. I., Reed, G. F. and Martin, J. L., Biotransformation of halothane, enflurane, isoflurane, and desflurane to trifluoroacetylated liver proteins: association between protein acylation and hepatic injury. Anesth. Analg. 1997. 84: 173–178.
  • 11
    Njoku, D. B., Talor, M. V., Fairweather, D., Frisancho-Kiss, S., Odumade, O. A. and Rose, N. R., A novel model of drug hapten-induced hepatitis with increased mast cells in the BALB/c mouse. Exp. Mol. Pathol. 2005. 78: 87–100.
  • 12
    Eliasson, E. and Kenna, J. G., Cytochrome P450 2E1 is a cell surface autoantigen in halothane hepatitis. Mol. Pharmacol. 1996. 50: 573–582.
  • 13
    Martin, J. L., Kenna, J. G., Martin, B. M., Thomassen, D., Reed, G. F. and Pohl, L. R., Halothane hepatitis patients have serum antibodies that react with protein disulfide isomerase. Hepatology 1993. 18: 858–863.
    Direct Link:
  • 14
    Njoku, D. B., Greenberg, R. S., Bourdi, M., Borkowf, C. B., Dake, E. M., Martin, J. L. and Pohl, L. R., Autoantibodies associated with volatile anesthetic hepatitis found in the sera of a large cohort of pediatric anesthesiologists. Anesth. Analg. 2002. 94: 243–249.
  • 15
    Njoku, D. B., Mellerson, J. L., Talor, M. V., Kerr, D. R., Faraday, N. R., Outschoorn, I. and Rose, N. R., Role of CYP2E1 immunoglobulin G4 subclass antibodies and complement in pathogenesis of idiosyncratic drug-induced hepatitis. Clin. Vaccine Immunol. 2006. 13: 258–265.
  • 16
    Anderson, J. S., Rose, N. R., Martin, J. L., Eger, E. I. and Njoku, D. B., Desflurane hepatitis associated with hapten and autoantigen-specific IgG4 antibodies. Anesth. Analg. 2007. 104: 1452–1453, table.
  • 17
    Gascan, H., Gauchat, J. F., Roncarolo, M. G., Yssel, H., Spits, H. and de Vries, J. E., Human B cell clones can be induced to proliferate and to switch to IgE and IgG4 synthesis by interleukin 4 and a signal provided by activated CD4+T cell clones. J. Exp. Med. 1991. 173: 747–750.
  • 18
    Gascan, H., Gauchat, J. F., Aversa, G., Van Vlasselaer, P. and de Vries, J. E., Anti-CD40 monoclonal antibodies or CD4+T cell clones and IL-4 induce IgG4 and IgE switching in purified human B cells via different signaling pathways. J. Immunol. 1991. 147: 8–13.
  • 19
    Zhang, K., Clark, E. A. and Saxon, A., CD40 stimulation provides an IFN-gamma-independent and IL-4-dependent differentiation signal directly to human B cells for IgE production. J. Immunol. 1991. 146: 1836–1842.
  • 20
    Svensson, L., Nandakumar, K. S., Johansson, A., Jansson, L. and Holmdahl, R., IL-4-deficient mice develop less acute but more chronic relapsing collagen-induced arthritis. Eur. J. Immunol. 2002. 32: 2944–2953.
    Direct Link:
  • 21
    Pohl, L. R., Kenna, J. G., Satoh, H., Christ, D. and Martin, J. L., Neoantigens associated with halothane hepatitis. Drug Metab. Rev. 1989. 20: 203–217.
  • 22
    Lohse, A. W., Manns, M., Dienes, H. P., Meyer zum Buschenfelde, K. H., and Cohen, I. R., Experimental autoimmune hepatitis: disease induction, time course and T-cell reactivity. Hepatology 1990. 11: 24–30.
    Direct Link:
  • 23
    Greve, B., Weissert, R., Hamdi, N., Bettelli, E., Sobel, R. A., Coyle, A., Kuchroo, V. K. et al., I kappa B kinase 2/beta deficiency controls expansion of autoreactive T cells and suppresses experimental autoimmune encephalomyelitis. J. Immunol. 2007. 179: 179–185.
  • 24
    Oliver, A. R., Lyon, G. M. and Ruddle, N. H., Rat and human myelin oligodendrocyte glycoproteins induce experimental autoimmune encephalomyelitis by different mechanisms in C57BL/6 mice. J. Immunol. 2003. 171: 462–468.
  • 25
    La, C. A., Van, K. L. and Fu, D. S., CD4+CD25+Tregs and NKT cells: regulators regulating regulators. Trends Immunol. 2006. 27: 322–327.
  • 26
    Liu, R., Van, K. L., La, C. A., Price, M., Campagnolo, D. I., Collins, M., Young, D. A. et al., Autoreactive T cells mediate NK cell degeneration in autoimmune disease. J. Immunol. 2006. 176: 5247–5254.
  • 27
    O'Garra, A., Vieira, P. L., Vieira, P. and Goldfeld, A. E., IL-10-producing and naturally occurring CD4+Tregs: limiting collateral damage. J. Clin. Invest. 2004. 114: 1372–1378.
  • 28
    Mills, K. H. and McGuirk, P., Antigen-specific regulatory T cells – their induction and role in infection. Semin. Immunol. 2004. 16: 107–117.
  • 29
    Skapenko, A., Kalden, J. R., Lipsky, P. E. and Schulze-Koops, H., The IL-4 receptor alpha-chain-binding cytokines, IL-4 and IL-13, induce forkhead box P3-expressing CD25+CD4+regulatory T cells from CD25-CD4+precursors. J. Immunol. 2005. 175: 6107–6116.
  • 30
    Jankovic, D., Kullberg, M. C., Feng, C. G., Goldszmid, R. S., Collazo, C. M., Wilson, M., Wynn, T. A. et al., Conventional T-bet(+)Foxp3(−) Th1 cells are the major source of host-protective regulatory IL-10 during intracellular protozoan infection. J. Exp. Med. 2007. 204: 273–283.
  • 31
    Anderson, C. F., Oukka, M., Kuchroo, V. J. and Sacks, D., CD4(+)CD25(−)Foxp3(−) Th1 cells are the source of IL-10-mediated immune suppression in chronic cutaneous leishmaniasis. J. Exp. Med. 2007. 204: 285–297.
  • 32
    Bourdi, M., Amouzadeh, H. R., Rushmore, T. H., Martin, J. L. and Pohl, L. R., Halothane-induced liver injury in outbred guinea pigs: role of trifluoroacetylated protein adducts in animal susceptibility. Chem. Res. Toxicol. 2001. 14: 362–370.
  • 33
    You, Q., Cheng, L., Reilly, T. P., Wegmann, D. and Ju, C., Role of neutrophils in a mouse model of halothane-induced liver injury. Hepatology. 2006. 44: 1421–1431.
    Direct Link:
  • 34
    James, L. P., Mayeux, P. R. and Hinson, J. A., Acetaminophen-induced hepatotoxicity. Drug Metab. Dispos. 2003. 31: 1499–1506.
  • 35
    Jaruga, B., Hong, F., Sun, R., Radaeva, S. and Gao, B., Crucial role of IL-4/STAT6 in T cell-mediated hepatitis: up-regulating eotaxins and IL-5 and recruiting leukocytes. J. Immunol. 2003. 171: 3233–3244.
  • 36
    Moscat, J., Rennert, P. and Diaz-Meco, M. T., PKCzeta at the crossroad of NF-kappaB and Jak1/Stat6 signaling pathways. Cell Death Differ. 2006. 13: 702–711.
  • 37
    Abdel-Razzak, Z., Loyer, P., Fautrel, A., Gautier, J. C., Corcos, L., Turlin, B., Beaune, P. and Guillouzo, A., Cytokines down-regulate expression of major cytochrome P-450 enzymes in adult human hepatocytes in primary culture. Mol. Pharmacol. 1993. 44: 707–715.
  • 38
    Lagadic-Gossmann, D., Lerche, C., Rissel, M., Joannard, F., Galisteo, M., Guillouzo, A. and Corcos, L., The induction of the human hepatic CYP2E1 gene by interleukin 4 is transcriptional and regulated by protein kinase C. Cell Biol. Toxicol. 2000. 16: 221–233.
View Full Article (HTML) Get PDF (457K)